temperatures worsened over time regardless of storage condition. The primary objective of the study was to generate data to precisely define optimal and acceptable methods for handling of hematopoietic stem cells prior to infusion. Therefore, refrigerated storage of PBSC and BM products appears to optimize the quality and quantity of the product. This is particularly relevant for PBSC products that may require multiple days for collection and/or transport.
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MOBILIZATION OF MURINE HSCs WITH AMD15057, A SMALL MOLE-CULE INHIBITOR OF CD49d (VLA4) Ramirez, P.A., Rettig, M., Holt, M., Ritchey, J., DiPersio, J.F. Washington University, St. Louis, MO.
Background: Developing hematopoietic stem cells (HSC) are largely confined to the bone marrow (BM) microenvironment. AMD3100 is a bicyclam molecule that potently, selectively, and reversibly antagonizes the binding of SDF-1 to CXCR4, and is the most promising mobilizing agent currently in clinical development. Significant data also support the role of VCAM1/VLA-4 axis in HSC homing and mobilization. In this study, we compared the kinetics and efficacy of HSC mobilization by AMD15057, a small molecule inhibitor of VLA-4, to AMD3100 and GCSF. Methods: To evaluate the mobilization of HSC progenitors, 8 week old 129/ B6 F1 mice (n 5 6 per group, 3 experiments) were left untreated (unmobilized) or treated with AMD15057 (1 mg/kg iv), AMD3100 (5 mg/kg sc), G-CSF (250 mg/kg/day Â 5 days) or the combination of AMD15057 and AMD3100. Total WBC and CFU-GM were determined at different time points for each mobilization regimen. For long-term competitive repopulation cell assays (LTRC), PBMCs from 3 CD45.2 1 unmobilized or mobilized mice (700 uL PB each) were pooled, mixed with a fixed number of 5 Â 10 5 CD45.1 1 BM mononuclear cells (MNC) (3:1 ratio) and injected into lethally irradiated CD45.1 1 /CD45.2 1 recipient mice. Chimerism was evaluated 18, 30, and 60 days after transplantation by flow cytometry. Results: A single iv injection of AMD15057 resulted in maximum mobilization of CFU-GM within 1 h compared to 3 h after AMD3100. Dramatic synergism of CFU-GM mobilization (120 fold over baseline) was seen when AMD15057 was combined with AMD3100. Furthermore, the combination of AMD15057 plus AMD3100 induced essentially equal mobilization of long term marrow competitive repopulating HSCs compared to GCSF treated donors (Table 1) . Overall survival at 60 days after transplantation was 100% for all cohorts, except for the unmobilized PB group (80% survival). Conclusions: Rapid mobilization of CFU-GM cells can be induced by AMD15057. AMD15057 synergized with AMD3100 to mobilize long term marrow repopulating HSCs. These results show that the VCAM1/VLA-4 axis is involved in HSC and progenitor cells trafficking and retention in the bone marrow microenvironment. Poster Session I 93
